Facebook Pixel image Angewomon EX1-030 | Digimon digimon Cards

digimon > Cards > Angewomon EX1-030

Angewomon EX1-030 image
set min mtgo
- A$ 0.00 0.0 tix
Icons of mtg
Name Angewomon EX1-030 Edit card
Type Digimon - ultimate vaccine archangel
Description Effect [When Attacking] If you have 3 or more security cards, 1 of your opponent's Digimon and all of your opponent's Security Digimon get -3000 DP for the turn. Inherited Effect [Your Turn][Once Per Turn] When a card is added to your security stacSee more
Artist Digimon Card Game
Set Digimon card game premium deck set [pd-01] #EX1-030
Wallpaper Angewomon EX1-030 Crop image Wallpaper download
Image Angewomon EX1-030 Full hd image download
⚠️

Tierlist

No Rank

Grade it yourself

Meta types

Edit card

Legality between formats

Edit card

About Angewomon EX1-030

Angewomon EX1-030, Digimon - ultimate vaccine archangel, designed by Digimon Card Game first released in Sep, 2024 in the set Premium Deck Set.

Angewomon EX1-030 would be particularly beneficial in a control or security-focused deck that aims to maintain a strong security presence while weakening the opponent's Digimon. Decks that utilize cards that add to the security stack, such as those featuring effects that allow for drawing or recovering cards, would synergize well with Angewomon’s inherited effect, enabling consistent DP reduction on opponent's Digimon. While there are other strong options like Seraphimon or other powerful ultimate-level Digimon with more versatile effects, Angewomon's ability to debilitate multiple opponent Digimon can be quite valuable in specific matchups. Overall, this card should see play in decks that can effectively leverage its unique strengths, especially in formats where controlling the board state is crucial.

Where to buy

Seller image Ebay.com

Visit store
Seller image Printing proxies

$ 0.75 Visit store

*This site contains affiliate links for which we may be compensated

Group by

Price alert ?

Alert me when price gets to

Price trend history

loading
Profile imageSign in and join the conversation

— Comments0

User profile image

Be the first to comment